avasimibe has been researched along with Coronary Artery Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charytan, D; Di Carli, MF; Dorbala, S; Ganz, P; McMahon, GT; Schelbert, HR | 1 |
Anderson, T; Blue, JW; Grégoire, J; Heinonen, T; Imus, J; L'Allier, PL; Lambert, J; Lespérance, J; Rodés, J; Tardif, JC | 1 |
Alfonso, F; Anderson, TJ; Bertrand, O; Blue, J; Grégoire, J; Hassan, A; Heinonen, T; Ibrahim, R; L'Allier, PL; Lespérance, J; McLain, R; Pressler, ML; Reeves, F; Rodés-Cabau, J; Schampaert, E; Tardif, JC; Title, LM | 1 |
Cohen, E; Grégoire, J; Guertin, MC; Heinonen, T; Ibrahim, R; Keller, PF; L'Allier, PL; Lavoie, MA; LeMay, M; Levesque, S; Tardif, JC | 1 |
Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC | 1 |
3 trial(s) available for avasimibe and Coronary Artery Disease
Article | Year |
---|---|
Coronary circulatory function in patients with the metabolic syndrome.
Topics: Acetamides; Acetates; Adenosine; Adolescent; Adult; Aged; Anticholesteremic Agents; Body Mass Index; C-Reactive Protein; Cholesterol; Cohort Studies; Coronary Artery Disease; Coronary Circulation; Data Interpretation, Statistical; Double-Blind Method; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Positron-Emission Tomography; Risk Factors; Sulfonamides; Sulfonic Acids; Vascular Resistance; Vasodilator Agents; Young Adult | 2011 |
Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.
Topics: Acetamides; Acetates; Adult; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Research Design; Statistics as Topic; Sulfonamides; Sulfonic Acids; Ultrasonography | 2002 |
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Topics: Acetamides; Acetates; Aged; Apolipoproteins B; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Image Processing, Computer-Assisted; Male; Middle Aged; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Sulfonamides; Sulfonic Acids; Treatment Failure; Ultrasonography, Interventional | 2004 |
2 other study(ies) available for avasimibe and Coronary Artery Disease
Article | Year |
---|---|
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Topics: Acetamides; Acetates; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Regression Analysis; Sulfonamides; Sulfonic Acids; Total Lung Capacity; Ultrasonography, Interventional | 2006 |
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional | 2007 |